Compare Garrett Motion Inc. Common Stock (GTX) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Garrett Motion Inc. Common Stock vs Hinge Health Inc. Class A Common Stock — how do they compare? Garrett Motion Inc. Common Stock trades at $25.32 (market cap $4.81B), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B). The key difference: Hinge Health Inc. Class A Common Stock is the larger of the two by market cap, and Garrett Motion Inc. Common Stock pays a 1.24% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Garrett Motion Inc. Common Stock for 6 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| GTX | HNGE | |
|---|---|---|
Market Cap | $4.81B | $8.48B |
Volume | 2,684,088 | 879,799 |
Sector | Consumer Cyclical | Health |
52-Week High | $36.23 | $105.14 |
52-Week Low | $12.50 | $31.17 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $6.06B | $8.10B |
Dividend Yield | 1.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Garrett Motion (GTX) trades at $25.78, showing minimal daily movement with a 0.08% gain. The stock exhibits bearish technical signals despite strong fundamental performance, including three consecutive quarterly earnings beats and improving profit margins. Recent news highlights the company's leadership in turbocharging and electrification technologies, with Q3 2026 results expected on October 29th. Institutional activity shows significant positions from BlackRock and Deutsche Bank, while analyst consensus remains positive with a $38 price target representing 47% upside potential.
GTX presents a compelling value opportunity with attractive valuation multiples (P/E 14.16, P/S 1.35) and consistent earnings outperformance. However, technical weakness and competitive pressures in automotive technology create near-term headwinds. The upcoming Q3 earnings report on October 29th will be crucial for validating the company's raised 2026 outlook and momentum trajectory.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Garrett Motion Inc. Common Stock
Garrett Motion develops turbocharging and air-boosting technologies for vehicles. Its products are used in internal combustion, hybrid, and other vehicle powertrains.
Read more on GTX →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
